The hard gelatin capsule as a dosage form itself facilitates and speeds-up development, through the flexibility and ease of formulation which it offers – along with the prospect of seamless continuity from Phase I through to the market place. As well, special products like the Capsugel® DBcaps® can speed-up double-blind clinical trials on a global level.
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest CHI content
Latest briefing from the Knowledge Center